What does CUSIP 09073Q105 represent in this 13F holders report?

CUSIP 09073Q105 is the security identifier for BVXV - Scinai Immunotherapeutics Ltd. - ADSs used to aggregate holder disclosures.

How many institutions held BVXV - Scinai Immunotherapeutics Ltd. - ADSs in Q3 2018?

11 institutional investors reported BVXV - Scinai Immunotherapeutics Ltd. - ADSs for Q3 2018. Use the holders table for investor-level position and value details.

Scinai Immunotherapeutics Ltd. - ADSs (BVXV)

CUSIP: 09073Q105

Q3 2018 13F Holders as of 30 Sep 2018

Security type / class: Equity / ADSs
Total 13F shares: 448,784
Total 13F value: $2,513,000
Share change: +1,537
SEC-reported price per share: $5.60
Number of holders: 11
Value change: +$7,535
Number of buys: 2
Number of sells: 2
Shares outstanding: 592,878

Security key

09073Q105

Report period

Q3 2018

Institutions

Top holders

BVXV full security history Ownership snapshot Full 13F holder table Scinai Immunotherapeutics Ltd. SEC filings Scinai Immunotherapeutics Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BVXV - Scinai Immunotherapeutics Ltd. - ADSs (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

IBEX INVESTORS LLC

Disclosed value leader

IBEX INVESTORS LLC

Comparable rows

0/11

Latest evidence

30 Jun 2018

13F Highest disclosed value: $2,395,000 11 rows are not safely comparable across share classes. Showing 1-6 of 11 holder rows.

Quick read

IBEX INVESTORS LLC has the largest disclosed position value at $2.4M.

0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens IBEX INVESTORS LLC's linked filing trail.

Disclosed position value Top 5

IBEX INVESTORS LLC $2.4M

BANK HAPOALIM BM $180K

Vantage Investment Advisors, LLC $140K

HighTower Advisors, LLC $112K

Psagot Value Holdings Ltd. $73K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 11 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
IBEX INVESTORS LLC	13F Company 13F	— denominator unverified	$2,395,000 359,000 shares	—	30 Jun 2018
BANK HAPOALIM BM	13F Company 13F	— denominator unverified	$180,000 26,926 shares	—	30 Jun 2018
Vantage Investment Advisors, LLC	13F Company 13F	— denominator unverified	$140,000 21,045 shares	—	30 Jun 2018
HighTower Advisors, LLC	13F Company 13F	— denominator unverified	$112,000 16,800 shares	—	30 Jun 2018
Psagot Value Holdings Ltd.	13F Company 13F	— denominator unverified	$73,000 10,877 shares	—	30 Jun 2018
DEUTSCHE BANK AG\	13F Company 13F	— denominator unverified	$44,000 6,600 shares	—	30 Jun 2018

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

448,784

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2018 vs Q2 2018 Across Filers

Q2 2018 holders

Q3 2018 holders

Holder diff

Investor	Q2 2018 Shares	Q3 2018 Shares	Share Diff	Share Chg %	Q2 2018 value	Q3 2018 value	Value change	Value Chg %